U.S. Rep. James Comer representing Kentucky's 1st Congressional District | Official U.S. House headshot
U.S. Rep. James Comer representing Kentucky's 1st Congressional District | Official U.S. House headshot
The House Committee on Oversight and Government Reform, under the leadership of Chairman James Comer (R-Ky.), will hold a hearing titled "Restoring Trust in FDA: Rooting Out Illicit Products." The session will critically assess the procedures within the U.S. Food and Drug Administration (FDA) focusing on reducing inefficiencies and bureaucracy. This initiative seeks to expedite the approval of innovative products while preventing the entry of illicit and counterfeit goods into the United States. There is also a strong emphasis on maintaining a safe and healthy food supply.
Chairman Comer expressed concerns about previous administrations, stating: “President Trump is taking action to Make America Healthy Again, rolling back the disastrous policies of the Biden Administration that put bureaucracy ahead of Americans. The Biden FDA stifled innovation with red tape while allowing counterfeit and dangerous products to flood our communities. The Biden border crisis only made things worse, allowing illicit drugs and unsafe goods to come into our country. President Trump’s crackdown at the southern border is already limiting the influx of illicit products coming into our nation. With newly confirmed FDA Commissioner Makary, we finally have a leader who will put Americans’ safety first, not special interests and bureaucrats. We look forward to working together to restore integrity to our food and drug supply and hearing from our expert witnesses on how we can achieve this goal."
The hearing is scheduled for Wednesday, April 9, 2025, at 10:00 AM ET in room HVC-210. It will include testimonies from experts such as Guy Bentley, Director of Consumer Freedom at Reason Foundation; Jonathan Miller, General Counsel at Hemp Roundtable and Partner-in-Charge at Frost, Brown, Todd; Richard Williams, Senior Affiliated Scholar at the Mercatus Center; and Shabbir Imber Safdar, Executive Director at The Partnership for Safe Medicines.
Members of the media are required to RSVP by Tuesday, April 8 at 5 PM ET to attend. Those interested can watch the proceedings via a livestream accessible online.